Obstet Gynecol Sci.  2013 May;56(3):198-200.

A case of successful salvage chemotherapy of recurrent ovarian sertoli-leydig cell tumor

• Lim S
• Kim NR
• Lee KB

Abstract

Sertoli-Leydig tumors tend to relapse early and due to their rarity, limited data are available regarding a role of chemotherapy in the management of Sertoli-Leydig cell tumors. We present a case of recurrent ovarian Sertoli-Leydig cell tumor whose salvage treatment was successful with paclitaxel and carboplatin chemotherapy.

Keyword

Ovary; Sertoli-Leydig cell tumor; Salvage therapy

MeSH Terms

Carboplatin
Female
Ovary
Paclitaxel
Recurrence
Salvage Therapy
Sertoli-Leydig Cell Tumor
Carboplatin
Paclitaxel

Figure

• 

  Fig. 1 Sertoli-Leydig cell tumor of the left ovary, with intermediate differentiation and retiform elements (H&E, ×100).

Reference

1. Koonings PP, Campbell K, Mishell DR Jr, Grimes DA. Relative frequency of primary ovarian neoplasms: a 10-year review. Obstet Gynecol. 1989. 74:921–926.

2. Young RH, Scully RE. Ovarian Sertoli-Leydig cell tumors. A clinicopathological analysis of 207 cases. Am J Surg Pathol. 1985. 9:543–569.

3. Roth LM, Anderson MC, Govan AD, Langley FA, Gowing NF, Woodcock AS. Sertoli-Leydig cell tumors: a clinicopathologic study of 34 cases. Cancer. 1981. 48:187–197.

4. Lantzsch T, Stoerer S, Lawrenz K, Buchmann J, Strauss HG, Koelbl H. Sertoli-Leydig cell tumor. Arch Gynecol Obstet. 2001. 264:206–208.

5. Colombo N, Parma G, Zanagnolo V, Insinga A. Management of ovarian stromal cell tumors. J Clin Oncol. 2007. 25:2944–2951.

6. Gershenson DM, Morris M, Burke TW, Levenback C, Matthews CM, Wharton JT. Treatment of poor-prognosis sex cord-stromal tumors of the ovary with the combination of bleomycin, etoposide, and cisplatin. Obstet Gynecol. 1996. 87:527–531.

7. Schwartz PE, Smith JP. Treatment of ovarian stromal tumors. Am J Obstet Gynecol. 1976. 125:402–411.

8. Saul PB. Sex cord stromal tumors. Clin Obstet Gynecol. 1985. 28:839–845.

9. Brown J, Shvartsman HS, Deavers MT, Burke TW, Munsell MF, Gershenson DM. The activity of taxanes in the treatment of sex cord-stromal ovarian tumors. J Clin Oncol. 2004. 22:3517–3523.